Sudo-Szopiska I, Kwiatkowska B, Prochorec-Sobieszek M, Maliski W
Artificial Intelligence may allow for more accurate personalisation of therapy to predict the optimum cocktail of mono agonist therapies based on the genetics and metabolomics of an individual and may quicken the process of drug development [70, 71]
Retatrutide Fatigue: How Long It Lasts and What to Expect Retatrutide fatigue is one of the most commonly reported side effects in clinical trials of this investigational triple receptor agonist, yet many people are uncertain how long it lasts and what to expect
Who qualifies for the BALANCE model Eligibility criteria are specific and clinical, similar to the clinical thresholds used when determining GLP-1 eligibility based on BMI
Some of the signs of gastroparesis include nausea, vomiting, abdominal pain, bloatedness, and loss of appetite
It remains in clinical trials and is still undergoing rigorous research and safety testing